Viracta Therapeutics Inc lost $1.32 per diluted share in fiscal year 2023. This represents a decrease of 1.5% from the prior fiscal year. Over the trailing 12 months, Q4 FY2023 through Q3 FY2024, the same line adds up to a loss of $1.10 per diluted share. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters Viracta Therapeutics Inc has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Viracta Therapeutics Inc's diluted earnings per share in fiscal year 2023?
Viracta Therapeutics Inc lost $1.32 per diluted share in fiscal year 2023.
How fast is Viracta Therapeutics Inc's diluted earnings per share growing?
Viracta Therapeutics Inc (VIRX) diluted earnings per share fell by 1.5% year over year, from -$1.30 to -$1.32 in fiscal year 2023.
What is Viracta Therapeutics Inc's diluted earnings per share over the last twelve months?
Viracta Therapeutics Inc (VIRX) reported a loss of $1.10 per diluted share over the trailing 12 months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.
What was Viracta Therapeutics Inc's diluted earnings per share in the most recent quarter?
Viracta Therapeutics Inc (VIRX) reported -$0.27 in diluted earnings per share in Q3 2024. This represents an increase of 18.2% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Viracta Therapeutics Inc (VIRX) reported on that line in every period on record.
